Target intelligence / Profile preview

Lipoylated tricarboxylic acid cycle enzymes

Molecular classification
Enzyme, Mitochondrial protein, Multi-enzyme complex
01

Overview

Lipoylated tricarboxylic acid (TCA) cycle enzymes are a group of mitochondrial multi-enzyme complexes, including pyruvate dehydrogenase (PDH) and alpha-ketoglutarate dehydrogenase (KGDH), that require the covalent attachment of lipoic acid for catalytic function (UniProt, 2024). These enzymes play a central role in cellular respiration by facilitating the conversion of metabolic intermediates into energy (Tsvetkov et al., 2022). The lipoylation process is regulated by the protein ferredoxin 1 (FDX1), which acts as a master regulator of this post-translational modification (Science, 2022). Recent research has identified these lipoylated enzymes as the key mediators of cuproptosis, a copper-dependent form of regulated cell death (Nature Chemical Biology, 2022). In this process, copper ionophores like elesclomol transport copper into the mitochondria, where the metal binds directly to the lipoylated components (PubChem, 2024). This binding leads to protein aggregation, loss of iron-sulfur cluster proteins, and severe proteotoxic stress, ultimately resulting in cell death (Frontiers in Oncology, 2022). This pathway is a promising therapeutic target in oncology, as many cancer cells exhibit increased mitochondrial metabolism and heightened sensitivity to copper-induced proteotoxicity compared to normal cells (Tsvetkov et al., 2022).

Other names
Lipoamide-containing enzymesAlpha-keto acid dehydrogenase complexesLipoylated mitochondrial enzymesCuproptosis targets
02

Mechanism of action

Induction of cuproptosis via copper-dependent aggregation of lipoylated enzymes, leading to proteotoxic stress and inhibition of the tricarboxylic acid cycle.

03

Biological functions

Tricarboxylic acid cycleEnergy metabolismCellular respirationRedox homeostasis
04

Disease associations

CancerMetabolic disorderNeurodegenerative disease
05

Safety considerations

Mitochondrial toxicitySystemic copper toxicityMetabolic acidosisOff-target effects on healthy metabolic tissues
06

Interacting drugs

Elesclomol

3 more in the full profile.

07

Biomarkers

FDX1 expressionLIAS expressionLIPT1 expressionProtein lipoylation levels

Beyond the preview

Go deeper on Lipoylated tricarboxylic acid cycle enzymes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lipoylated tricarboxylic acid cycle enzymes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call